TG Therapeutics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by TG Therapeutics, Inc. on January 22, 2013, covering the event date of January 18, 2013. The filing addresses corporate governance matters regarding the scheduling of the fiscal 2013 Annual Meeting of Stockholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to corporate governance notifications and contains no financial performance data.
Material Changes
The primary material change involves the rescheduling of the fiscal 2013 Annual Meeting of Stockholders to June 5, 2013, at 10:00 a.m. EST. This date is more than 30 days after the anniversary of the 2012 annual meeting. Consequently, the previous deadlines for qualified stockholder nominations are no longer applicable.
Guidance, Outlook, and Risks
The filing provides no financial guidance, outlook, or management commentary on business operations. It does not disclose new risks, contingencies, or unusual items. The document solely updates the timeline for shareholder nominations, which are now due on or after March 7, 2013, and before April 6, 2013, to align with the distribution of proxy materials in April 2013.
Key Facts for Investor Verification
- Annual Meeting Date: June 5, 2013.
- Meeting Location: Alston & Bird LLP, 90 Park Avenue, New York, New York 10016.
- Updated Nominations Window: March 7, 2013, to April 6, 2013.
- Reason for Change: The meeting date is more than 30 days after the prior year's anniversary.